All the latest packaging trends for life sciences, all at PACK EXPO East
Explore new packaging solutions for life sciences, all in one convenient location at PACK EXPO East, March 18 – 20 in Philadelphia.

Contamination Issue Leads to Pain Reliever Spray Recall

In the affected lot, a low level of benzene came from the propellant in the can.

Pharmacy Getty Images 509757912

According to a recent Newsweek article, Insight Pharmaceuticals has voluntarily recalled one lot of aerosol pain reliever spray, commonly used to treat symptoms from minor cuts, burns, scrapes, and more. In a statement, Insight noted, “While benzene is not an ingredient in any Americaine® 20% Benzocaine Topical Anesthetic Spray products, a recent review by our manufacturer and their third-party lab found that a sample from one lot of the product showed a low level of benzene came from the propellant that sprays the product out of the can.”

Classified as a human carcinogen, benzene exposure via inhalation, oral, or dermal routes can potentially lead to cancers including leukemia and bone marrow cancer at certain levels. However, humans are exposed to benzene daily both indoors and outdoors from a variety of sources including from glues, car exhaust, smoke, and industrial emissions according to the CDC. 

Insight stated that no adverse events have been reported to date, and no other lots are affected. The recall is being performed “out of an abundance of caution.”

Related from FDA:

Cipla Issues Voluntary Nationwide Recall of Six Batches of Albuterol Sulfate Inhalation Aerosol, 90 mcg (200 Metered Inhalation) Due to Container Defect

Recall of Certain Saline and Sterile Water Medical Products Associated with Nurse Assist: FDA Safety Communication            


 

Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts
Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub